ADC Therapeutics SA (ADCT): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 27.07.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name ADC Therapeutics SA
Mitarbeiter 188
Handelsplatz NYSE
Ticker Symbol ADCT
IPO Datum 1979-03-16
Adresse BiopOle, Epalinges, Switzerland, 1066
Webseite https://www.adctherapeutics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Ameet Mallik M.B.A., M.S. | CEO & Director |
| 2 | Mr. Jose I. Carmona M.B.A. | Chief Financial Officer |
| 3 | Dr. Mohamed Zaki M.D., Ph.D. | Chief Medical Officer |
| 4 | Ms. Lisa Michelle Kallebo | Corporate Controller & Chief Accounting Officer |
| 5 | Dr. David S. Ege Ph.D. | Chief Technical Officer |
| 6 | Ms. Nicole Riley | Head of Investor Relations & Corporate Communications |
| 7 | Mr. Peter J. Graham Esq. | Secretary and Chief Legal & Compliance Officer |
| 8 | Ms. Kimberly Pope | Senior VP & Chief People Officer |
| 9 | Ms. Kristen Harrington-Smith | Chief Commercial Officer |
| 10 | Ms. Marcy Graham | Investor Relations Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Redmile Group, LLC | 12,16% | 17,79 Mio. USD |
| 2 | TCG Crossover Management, LLC | 8,96% | 13,10 Mio. USD |
| 3 | Prosight Management, LP | 6,53% | 9,55 Mio. USD |
| 4 | BlackRock Inc | 4,91% | 7,19 Mio. USD |
| 5 | Eventide Asset Management, LLC | 4,48% | 6,56 Mio. USD |
| 6 | Nantahala Capital Management, LLC | 4,40% | 6,44 Mio. USD |
| 7 | Morgan Stanley - Brokerage Accounts | 3,00% | 4,38 Mio. USD |
| 8 | Point72 Asset Management, L.P. | 2,66% | 3,89 Mio. USD |
| 9 | Millennium Management LLC | 2,45% | 3,59 Mio. USD |
| 10 | The Goldman Sachs Group Inc | 1,30% | 1,90 Mio. USD |
| 11 | State Street Corp | 1,23% | 1,80 Mio. USD |
| 12 | Bank of America Corp | 1,04% | 1,52 Mio. USD |
| 13 | Orbimed Advisors, LLC | 1,04% | 1,52 Mio. USD |
| 14 | Geode Capital Management, LLC | 0,95% | 1,38 Mio. USD |
| 15 | Vanguard Group Inc | 0,89% | 1,30 Mio. USD |
| 16 | Vanguard Portfolio Management, LLC | 0,81% | 1,19 Mio. USD |
| 17 | Junked Platinum Investment Management Ltd | 0,78% | 1,14 Mio. USD |
| 18 | BNP Paribas Arbitrage, SA | 0,68% | 0,99 Mio. USD |
| 19 | Blue Owl Capital Holdings LP | 0,58% | 0,84 Mio. USD |
| 20 | Panagora Asset Management Inc | 0,54% | 0,80 Mio. USD |